Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres.
A 120-day poly(D,L-lactide) (PLA) microsphere delivery system for a luteinizing hormone-releasing hormone (LHRH) analogue, leuprolide, was prepared and evaluated. Leuprolide microspheres were prepared with PLA (m.w. 11000 Da) by a dispersion/solvent extraction-evaporation method and characterized for drug load by HPLC, particle size by laser diffractometry and surface morphology by scanning electron microscopy. In vitro peptide release and polymer degradation were studied using a modified dialysis method. Serum peptide and testosterone levels were analyzed after subcutaneous administration using a rat model. Spherical microspheres with a mean diameter of 52 microm containing 13.4% peptide released 10% of the peptide within 24 h, followed by a linear release for 150 days. Serum leuprolide levels increased immediately after administration of the microspheres to 45.6 ng/ml, but then fell to 4.3 ng/ml at 15 days and approximately 2.0 ng/ml at 30 days where they remained for 120 days. The testosterone levels increased initially to 15 ng/ml and then decreased to below 0.5 ng/ml by day 4 where they remained for 120 days. In conclusion, a 120-day microsphere formulation of leuprolide was developed with excellent controlled peptide release characteristics and in vivo efficacy.
Woo
B H
BH
Faculty of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 800 Rose Street, Lexington, KY 40536, USA.
Kostanski
J W
JW
Gebrekidan
S
S
Dani
B A
BA
Thanoo
B C
BC
DeLuca
P P
PP
D000818:Animals; D006863:Hydrogen-Ion Concentration; D016729:Leuprolide / Q000008:administration & dosage* / Q000097:blood / Q000737:chemistry; D008297:Male; D008863:Microspheres; D008970:Molecular Weight; D011091:Polyesters / Q000008:administration & dosage*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012995:Solubility; D013739:Testosterone / Q000097:blood
D011091:Polyesters; D013739:Testosterone; C033616:poly(lactide); D016729:Leuprolide